Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.
about
Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinomaEmerging treatment options for nasopharyngeal carcinomaRole of chemotherapy in nasopharyngeal carcinomaOutpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study.Current management strategy of nasopharyngeal carcinoma.IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinomaChemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysisNew therapeutic strategies for the treatment and prevention of head and neck cancer.Treatment of locally advanced head and neck cancer: historical and critical review.Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study.The effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapyFailure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study.State-of-the-art management of nasopharyngeal carcinoma: current and future directionsRole of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative RadiotherapyCurrent and emerging treatment options for nasopharyngeal carcinoma.Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysisFluorodeoxyglucose-positron emission tomography in carcinoma nasopharynx: Can we predict outcomes and tailor therapy based on postradiotherapy fluorodeoxyglucose-positron emission tomography?The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT.Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy.Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma.Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma.Head and neck cancer: present status and future prospects of adjuvant chemotherapy.Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study.Nasopharyngeal carcinoma: local control by megavoltage irradiation.The role of chemotherapy in the management of nasopharyngeal carcinoma.Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma.The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.Neoadjuvant chemotherapy with different dose regimens of docetaxel, cisplatin and fluorouracil (TPF) for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.Radiation therapy combined with (or without) cisplatin-based chemotherapy for patients with nasopharyngeal cancer: 15-years experience of a single institution in Korea.Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.Long-term outcomes of alternating chemoradiotherapy in patients with advanced nasopharyngeal cancer: a single-centre experience over the last decade.External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study
P2860
Q24243898-2BAEEB52-858D-4019-8D42-00EE86E30043Q26995560-958802A8-DF58-4DA6-909B-34999E355513Q27022454-92DEB99B-B113-4D0C-82A7-9CD3C9266C4FQ33346719-F1D9A391-BD66-4CF0-AAE1-6E39A8D27A3DQ33432452-0041180A-1206-49A7-B458-0A919D5FCFABQ33763893-740C722F-AD2D-4667-903C-48027C5FF267Q33764579-6F6F9DD3-6465-4976-AD0D-7D4D783367D5Q33889336-6174D7EE-0B3E-49CE-B983-2257FB957000Q33889391-51B5E171-B8EF-4DD1-9D74-7861B742C923Q34090976-A4376EF6-0888-4259-8E88-1B0D8EED4789Q34157174-4D2D4DFF-52ED-4E4A-A431-B34585A00A28Q35103235-43F803D0-C170-4149-BA70-658D7B22111AQ35208691-90C94DC7-9762-4F3A-83F5-55EE25FF82C5Q35717112-9F1FF94C-7B66-453B-9C87-72302E2EBA1DQ36065641-620A10C9-A42E-43F7-BAFD-6D2CEE2D3948Q36187049-00C8D410-86DB-4AC1-9858-C8EA8CE4408FQ36359374-D194C43B-8C8D-4F70-9594-47D68C0AA62AQ36621526-C47A3CCE-1717-4083-9D64-7D70610D364CQ36690259-89DC6F68-950A-484F-B84F-B6099DEEA6B1Q36696385-9130226A-C61F-4A7B-AE20-456978079D84Q37190511-0500D3C2-0F62-41D9-B231-F4B4B66DD55AQ37353983-698E36FE-2BBB-46F6-A512-36AE0D969DA1Q37904839-ED312F05-A20E-470C-85E8-2B46B2617BA3Q40078689-AE54EB6A-B887-4266-BA9A-F90F0ABBAB05Q40095250-DEB90F58-95A1-45FC-B770-0701FE001B2CQ40578964-1C6CFBA8-F8BA-4718-8698-CF73D13C826AQ40680191-91C2F79C-B11D-4B80-910D-8132128BFEFEQ41078339-A8160876-3E41-4541-9F2F-F8E89A4BCEFCQ41722731-172DDC2C-01C5-4271-B148-F6D5C8CA2795Q43632373-0CBE2A76-C48A-4376-87CA-4CF15B9F0B24Q45772336-9AB15AC3-0741-4230-9C6F-12A54E99D797Q47122053-0BE6737E-C63C-4FC5-8946-98671FB501B3Q47142016-4BC4BBCE-5797-43EF-9EF9-6676C714C682Q50321714-B31467A0-5AB6-4262-AA1A-9F65916DA8FEQ50430866-D45266BC-19EE-4A7C-83B2-9CB92EBD3B9EQ55332260-5145F22A-720D-4783-80B8-B5578395461AQ55426985-3456A450-3F4C-42BC-8C8F-7D37B9EE9C51Q57161584-7B78C902-C198-4028-A043-5317745B7F32
P2860
Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Adjuvant chemotherapy with vin ...... multicenter randomized study.
@en
Adjuvant chemotherapy with vin ...... multicenter randomized study.
@nl
type
label
Adjuvant chemotherapy with vin ...... multicenter randomized study.
@en
Adjuvant chemotherapy with vin ...... multicenter randomized study.
@nl
prefLabel
Adjuvant chemotherapy with vin ...... multicenter randomized study.
@en
Adjuvant chemotherapy with vin ...... multicenter randomized study.
@nl
P2093
P1476
Adjuvant chemotherapy with vin ...... multicenter randomized study.
@en
P2093
E Marubini
M Del Vecchio
P Boracchi
R Molinari
P304
P356
10.1200/JCO.1988.6.9.1401
P407
P577
1988-09-01T00:00:00Z